The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 08, 2019

Filed:

Jul. 10, 2017
Applicant:

Bruce Perry, Carefree, AZ (US);

Inventor:

Bruce Perry, Carefree, AZ (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/48 (2006.01); A61K 31/14 (2006.01); A61K 31/7076 (2006.01); A61K 31/56 (2006.01); A61K 31/36 (2006.01); A61K 45/06 (2006.01); A61K 36/28 (2006.01); A61K 36/738 (2006.01); A61K 36/78 (2006.01); A61K 36/744 (2006.01); A61K 36/69 (2006.01); A61K 36/815 (2006.01);
U.S. Cl.
CPC ...
A61K 9/4808 (2013.01); A61K 9/4858 (2013.01); A61K 9/4891 (2013.01); A61K 31/14 (2013.01); A61K 31/36 (2013.01); A61K 31/56 (2013.01); A61K 31/7076 (2013.01); A61K 36/28 (2013.01); A61K 36/69 (2013.01); A61K 36/738 (2013.01); A61K 36/744 (2013.01); A61K 36/78 (2013.01); A61K 36/815 (2013.01); A61K 45/06 (2013.01); A61K 2236/33 (2013.01);
Abstract

The invention comprises a biomedically active/delivery site specific capsule-in-capsule liver supplement and method of use thereof. A first set of constituents, of an outer capsule, of a capsule-in-capsule liver supplement, comprises one or more of choline and phosphatidylcholine; a second set of constituents, of an inner capsule, comprise one or more of methionine, glycyrrhetinic acid, silymarin, and phosphatidylcholine; and either capsule optionally contains one or more liver aiding/regulating natural products, where the outer capsule dissolves in the stomach and the inner capsule dissolves in the small intestine. Thus, the dual dissolution process in controlled environments results in complementary and synergistic delivery of liver regulating molecules in a bioavailable form ready for transport through the wall of the small intestine. Further, constituents of the capsule-in-capsule liver supplement include multiple inputs into the methionine cycle, which facilitates/synergistically aids the body's use of the methionine cycle, such as in liver regulation.


Find Patent Forward Citations

Loading…